Biotech Values

[stock1ace1]

CLSN .32 * Phase III Coming * Links


*** Must Read DD On Phase III optima Study Coming ***

The CFDA informed the Company that if the ongoing Phase III OPTIMA Study is successful, the trial could serve as the basis for a direct regulatory filing in China without the need to file for prior approval in the U.S. or European Union which is currently required for foreign company application. This would allow the Company to accelerate its plans for a regulatory filing in China and, if approved, provide for a significantly earlier launch date in China than originally expected.

*** 6 Month Chart ***
http://stockcharts.com/h-sc/ui?s=CLSN&p=D&yr=0&mn=6&dy=0&id=p92687439023

* CLSN Under Huge Short Attack *
~~> http://regsho.finra.org/regsho-Index.html